Photochemical internalization for virusmediated molecule delivery into the cyosol

Details for Australian Patent Application No. 2002222104 (hide)

Owner PCI Biotech AS

Inventors Hogset, Anders; Maelandsmo, Gunnhild Mari; Engesaeter, Birgit Ovstebo; Berg, Kristian; Prasmickaite, Lina

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002222104

PCT Pub. Number WO02/44395

Priority 0029405 01.12.00 GB; 0114696 15.06.01 GB; 0029142 29.11.00 GB

Filing date 29 November 2001

Wipo publication date 11 June 2002

Acceptance publication date 28 June 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Event Publications

28 June 2007 Application Accepted

  Published as AU-B-2002222104

1 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002222105

2002222103